KEGG: spo:SPAC57A10.07
STRING: 4896.SPAC57A10.07.1
SPAC57A10.07 is a protein encoded in the Schizosaccharomyces pombe genome that remains functionally uncharacterized despite being identified during genome sequencing. It is classified as "uncharacterized" because its biological function, biochemical activity, and structural properties remain largely unknown. The protein lacks significant homology with proteins of known function, making it difficult to predict its role based on sequence comparison alone. Uncharacterized proteins represent significant opportunities for discovering novel biological mechanisms and pathways in this model organism, which shares approximately 70% of its genes as orthologs with human genes .
While specific structural information about SPAC57A10.07 is limited, structural features can be predicted using computational tools. These analyses typically include:
| Feature | Prediction Method | Information Obtained |
|---|---|---|
| Primary sequence | Genome sequencing | Amino acid sequence |
| Molecular weight | Computation based on AA composition | Approximate size |
| Isoelectric point | Computation based on charged residues | pH at which the protein has no net charge |
| Secondary structure | Algorithms (PSIPRED, JPred) | α-helices, β-sheets, random coils |
| Domains and motifs | InterPro, Pfam, SMART | Functional domains |
| Transmembrane regions | TMHMM, Phobius | Potential membrane-spanning segments |
| Signal peptides | SignalP | Potential for secretion |
| Post-translational modifications | NetPhos, NetOGlyc | Predicted modification sites |
These computational predictions should be experimentally validated using techniques such as circular dichroism spectroscopy for secondary structure confirmation or limited proteolysis to identify domain boundaries. S. pombe proteins often contain unique post-translational modifications that may not be accurately predicted by general algorithms .
Understanding the regulation of SPAC57A10.07 requires a multifaceted experimental approach:
Transcriptional Regulation Analysis:
RNA sequencing (RNA-seq) to measure SPAC57A10.07 mRNA levels under various conditions
Chromatin immunoprecipitation sequencing (ChIP-seq) to identify transcription factors binding to the promoter region
Promoter analysis using reporter genes to determine critical regulatory elements
Experimental Methodology:
Replace the native promoter with the thiamine-repressible nmt1 promoter or the rapidly inducible urg1 promoter (which allows induction within 30 minutes compared to the 14-20 hours required for nmt1 induction)
Create promoter deletion constructs fused to a reporter gene to identify critical regulatory elements
Perform RNA-seq across different growth conditions and cell cycle stages to create an expression profile
Utilize the S. pombe deletion library to identify trans-acting factors affecting SPAC57A10.07 expression
A typical RNA-seq experimental design might include:
| Condition | RPKM Value | Fold Change vs. Control | p-value |
|---|---|---|---|
| Vegetative growth | Reference | 1.0 | - |
| Nitrogen starvation | Measured | Calculated | Statistical |
| Glucose limitation | Measured | Calculated | Statistical |
| Oxidative stress | Measured | Calculated | Statistical |
| Meiosis | Measured | Calculated | Statistical |
| Cell cycle phases | Measured | Calculated | Statistical |
Successful expression of recombinant SPAC57A10.07 requires careful consideration of expression systems and conditions:
Expression System Selection:
Homologous expression in S. pombe maintains native folding and post-translational modifications
Heterologous expression in E. coli offers high yield but may lack proper modifications
Expression in S. cerevisiae provides a compromise between yield and eukaryotic processing
Optimization Strategies:
Codon optimization for the chosen expression host
Use of appropriate promoters (e.g., nmt1 or urg1 for S. pombe)
Addition of fusion tags for enhanced solubility and purification (His, GST, MBP)
Inclusion of appropriate signal sequences if secretion is desired
For S. pombe expression, methodology can be adapted from genetic engineering approaches used for other recombinant proteins in this organism:
Cloning SPAC57A10.07 into an integration vector like pYIplac128
Transformation into S. pombe using chemical transformation methods
Induction of expression using the nmt1 promoter (repressed by thiamine) or urg1 promoter for rapid induction
A comparative expression optimization table might look like:
| Expression System | Vector | Promoter | Tag | Expression Level | Solubility | Yield (mg/L) |
|---|---|---|---|---|---|---|
| E. coli BL21(DE3) | pET28a | T7 | His6 | Variable | Variable | Variable |
| S. pombe | pREP1 | nmt1 | FLAG | Variable | Variable | Variable |
| S. pombe | pREP1 | urg1 | His6 | Variable | Variable | Variable |
| S. cerevisiae | pYES2 | GAL1 | HA | Variable | Variable | Variable |
Purification of SPAC57A10.07 for structural studies requires a strategic approach to maintain protein integrity:
Cell Lysis Methods:
For S. pombe, cell disruption by sonication as documented in recombinant protein studies
Glass bead lysis using a Ribolyser as described in protocols for fission yeast
French press or homogenization for larger scale preparations
Purification Strategy:
Affinity Chromatography:
Immobilized metal affinity chromatography (IMAC) for His-tagged proteins
Glutathione-Sepharose for GST fusion proteins
Antibody-based purification for epitope-tagged proteins
Ion Exchange Chromatography:
Based on the predicted isoelectric point of SPAC57A10.07
Anion exchange (Q-Sepharose) for negatively charged proteins
Cation exchange (SP-Sepharose) for positively charged proteins
Size Exclusion Chromatography:
Final polishing step to remove aggregates and achieve high purity
Also provides information about the oligomeric state of the protein
A typical purification table should track progress through each step:
| Purification Step | Total Protein (mg) | SPAC57A10.07 (mg) | Purity (%) | Yield (%) | Specific Activity |
|---|---|---|---|---|---|
| Crude Extract | Starting | Estimated | Initial | 100 | Baseline |
| Affinity Chromatography | Reduced | Enriched | Increased | Calculated | Increased |
| Ion Exchange | Further reduced | Further enriched | Higher | Calculated | Higher |
| Size Exclusion | Final | Final | >95 | Final | Highest |
For structural studies, buffer optimization for stability and removal of heterogeneity from post-translational modifications may be necessary, especially considering S. pombe's complex glycosylation patterns .
Phenotypic analysis of SPAC57A10.07 deletion or overexpression strains can provide direct insights into its function:
Generation of Deletion and Overexpression Strains:
Gene deletion using homologous recombination (PCR-based approach) or CRISPR-Cas9
Overexpression using strong promoters (nmt1) or additional gene copies
Creation of conditional alleles if deletion is lethal
Phenotypic Analysis:
Growth Characteristics:
Stress Sensitivity:
Cell Wall and Morphology Analysis:
A pilot study of gene deletion in S. pombe found that approximately 17.5% of genes are essential, compared to 17.8% in budding yeast . The essentiality of SPAC57A10.07 would be a critical piece of information determining the experimental approach.
Phenotypic data should be systematically presented:
| Phenotypic Trait | Wild Type | SPAC57A10.07Δ | SPAC57A10.07-OE | p-value |
|---|---|---|---|---|
| Doubling Time (min) | Control | Measured | Measured | Statistical |
| Cell Length at Division (μm) | Control | Measured | Measured | Statistical |
| Septation Index (%) | Control | Measured | Measured | Statistical |
| Viability at 36°C (%) | Control | Measured | Measured | Statistical |
| H₂O₂ Sensitivity | Control | Measured | Measured | Statistical |
| Mating/Sporulation Efficiency | Control | Measured | Measured | Statistical |
Computational methods offer powerful approaches to predict functions of uncharacterized proteins like SPAC57A10.07:
Sequence-Based Methods:
Homology Detection:
PSI-BLAST, HHpred, and HMMER for detecting remote homologs
Jackhmmer for iterative sequence searches
Domain and Motif Analysis:
InterPro, Pfam, SMART for domain identification
ELM for short functional motifs
COILS for coiled-coil predictions
Structural Predictions:
AlphaFold2, RoseTTAFold for 3D structure prediction
I-TASSER, Phyre2 for fold recognition
FoldSeek for structural homology searches
Genomic Context Methods:
Phylogenetic Profiling:
Correlation of presence/absence patterns across species
Identification of functionally linked proteins with similar evolutionary profiles
Gene Expression Correlation:
Co-expression analysis using public transcriptomic datasets
Identification of genes with similar expression patterns
From genomic analyses, we know that S. pombe shares genes with higher eukaryotes that are not present in S. cerevisiae, such as RNAi machinery genes . If SPAC57A10.07 falls into this category, it may have functions conserved with multicellular organisms rather than with budding yeast.
Results from computational analyses should be systematically evaluated:
| Prediction Method | Prediction Result | Confidence Score | Supporting Evidence |
|---|---|---|---|
| AlphaFold2 | Structural model | pLDDT score | Structural similarities |
| InterPro | Domain predictions | E-value | Domain architecture |
| STRING | Functional associations | Combined score | Evidence types |
| ELM | Linear motif predictions | p-value | Conservation |
| Co-expression Analysis | Co-expressed genes | Correlation coefficient | Biological conditions |
CRISPR-Cas9 technology offers powerful tools for studying SPAC57A10.07 function in S. pombe:
CRISPR-Cas9 Applications:
Gene Knockout:
Complete deletion of the SPAC57A10.07 gene
Introduction of frameshift mutations or premature stop codons
Gene Editing:
Introduction of point mutations to study specific residues
Domain deletions or swaps to assess domain functions
Insertion of epitope tags for protein detection and purification
Gene Regulation:
CRISPRi (interference) using catalytically inactive Cas9 (dCas9) to repress transcription
CRISPRa (activation) using dCas9 fused to activator domains to enhance transcription
Experimental Design for S. pombe:
gRNA Design:
Selection of target sites with minimal off-target effects
Consideration of S. pombe PAM preference
Design of multiple gRNAs targeting different regions for efficiency comparison
Delivery Method:
Plasmid-based expression of Cas9 and gRNA
Integration of Cas9 into the genome under inducible promoters
Direct delivery of Cas9-gRNA ribonucleoprotein complexes
S. pombe researchers have developed techniques to study replication fork arrest and restart , and CRISPR-Cas9 could be used to introduce specific mutations in SPAC57A10.07 to test if it plays a role in these processes.
Design of CRISPR experiments should be carefully documented:
| Target Region | gRNA Sequence | PAM | Efficiency (%) | Off-target Score | Purpose |
|---|---|---|---|---|---|
| Exon 1 | Designed sequence | NGG | Measured | Calculated | Knockout |
| Catalytic site | Designed sequence | NGG | Measured | Calculated | Point mutation |
| Promoter | Designed sequence | NGG | Measured | Calculated | CRISPRi |
| 3' end | Designed sequence | NGG | Measured | Calculated | Epitope tagging |
Post-translational modifications (PTMs) can significantly affect protein function, localization, and interactions:
Identification of PTMs:
Mass Spectrometry-Based Approaches:
Enrichment strategies for phosphorylation (TiO₂, IMAC)
Enrichment for ubiquitination (K-ε-GG antibodies)
Glycan analysis by lectin affinity or hydrazide chemistry
Targeted and untargeted PTM discovery using various fragmentation methods
Biochemical Methods:
Western blotting with modification-specific antibodies
Mobility shift assays (Phos-tag)
ProQ Diamond staining for phosphoproteins
Functional Analysis of PTMs:
Site-Directed Mutagenesis:
Mutation of modification sites to non-modifiable residues (e.g., S→A for phosphorylation)
Phosphomimetic mutations (e.g., S→D or S→E)
Analysis of mutant phenotypes in vivo
S. pombe proteins undergo various post-translational modifications, including O-mannosylation and N-glycosylation. Research has shown competition between these modifications, where unusual N-glycosylation sites can be masked by O-mannosylation . This interplay could be particularly relevant for SPAC57A10.07 function.
Data on PTMs should be systematically presented:
| Modification | Site | Enzyme Responsible | Stimulus | Functional Effect |
|---|---|---|---|---|
| Phosphorylation | Residue(s) | Kinase(s) | Condition | Effect on function |
| Ubiquitination | Residue(s) | E3 ligase | Condition | Effect on function |
| Glycosylation | Residue(s) | Glycosyltransferase | Condition | Effect on function |
High-throughput approaches offer systematic ways to identify the function of uncharacterized proteins:
Genomic Approaches:
Synthetic Genetic Array (SGA) Analysis:
Systematic creation of double mutants with all viable deletion strains
Identification of genetic interactions (synthetic lethality, suppression)
Inference of function based on interaction patterns
Chemical-Genetic Profiling:
Testing sensitivity of SPAC57A10.07 deletion or overexpression to a library of compounds
Comparison with profiles of known mutants to identify pathway connections
Proteomic Approaches:
Global Protein-Protein Interaction Mapping:
Systematic Y2H or AP-MS screening
Comparison of interactome with proteins of known function
Thermal Proteome Profiling (TPP):
Analysis of protein thermal stability changes upon ligand binding
Identification of potential substrates or interacting molecules
A pilot gene deletion project in S. pombe assessed the feasibility of a genome-wide deletion project and estimated the percentage of essential genes to be 17.5% . Such systematic deletion projects provide valuable resources for functional genomics studies that can be leveraged to understand SPAC57A10.07.
Results from high-throughput studies should be presented with appropriate statistical analysis:
| Approach | Key Findings | Statistical Significance | Related Processes |
|---|---|---|---|
| SGA | Genetic interactions | p-value, FDR | Biological processes |
| Metabolomics | Altered metabolites | p-value, FDR | Metabolic pathways |
| Chemical-Genetic | Drug sensitivities | p-value, FDR | Cellular responses |
| Interactome | Interacting proteins | p-value, FDR | Molecular complexes |
Crystallizing proteins for structural studies presents significant challenges, particularly for uncharacterized proteins:
Common Crystallization Challenges:
Protein Stability and Homogeneity:
Aggregation propensity due to exposed hydrophobic patches
Conformational heterogeneity affecting crystal packing
Post-translational modifications causing sample heterogeneity
Intrinsically Disordered Regions (IDRs):
Flexible regions hindering crystal formation
Strategies include limited proteolysis to remove flexible regions or construct optimization
Optimization Strategies:
Construct Design:
Bioinformatic prediction of domain boundaries
Creation of multiple constructs with different N- and C-terminal boundaries
Removal of predicted disordered regions
Crystallization Screening:
High-throughput screening of diverse crystallization conditions
Variation of protein concentration, temperature, and precipitants
Addition of ligands or binding partners to stabilize specific conformations
S. pombe proteins can be successfully expressed and purified for biochemical and structural studies , but the specific challenges for SPAC57A10.07 would depend on its unique properties.
Crystallization optimization results should be systematically tracked:
| Construct | Boundaries | Crystallization Condition | Diffraction Resolution | Space Group | Unit Cell Parameters |
|---|---|---|---|---|---|
| Full-length | Complete | Condition tested | Resolution achieved | Group | Parameters |
| Domain 1 | Residues x-y | Condition tested | Resolution achieved | Group | Parameters |
| Domain 2 | Residues z-w | Condition tested | Resolution achieved | Group | Parameters |
Identifying protein-protein interactions (PPIs) for SPAC57A10.07 can provide critical insights into its function:
Yeast Two-Hybrid (Y2H) Screening:
Using SPAC57A10.07 as bait against an S. pombe cDNA library
Verification of interactions by reverse Y2H and co-immunoprecipitation
Library screening approach can identify novel interactors
Affinity Purification-Mass Spectrometry (AP-MS):
Expression of tagged SPAC57A10.07 in S. pombe
Purification of protein complexes under native conditions
Mass spectrometric identification of co-purified proteins
Differentiation between specific interactors and contaminants using quantitative approaches
Proximity-Dependent Biotin Identification (BioID):
Fusion of SPAC57A10.07 with a biotin ligase (BirA*)
Biotinylation of proximal proteins in vivo
Streptavidin purification and mass spectrometry identification
A systematic interaction mapping would be presented as:
| Interacting Protein | UniProt ID | Gene Name | Interaction Type | Detection Method | Validation |
|---|---|---|---|---|---|
| Protein 1 | ID | gene | physical/genetic | AP-MS/Y2H/BioID | Method |
| Protein 2 | ID | gene | physical/genetic | AP-MS/Y2H/BioID | Method |
| Protein 3 | ID | gene | physical/genetic | AP-MS/Y2H/BioID | Method |
S. pombe protein interaction data can reveal connections to specific pathways, as demonstrated in the interaction mapping of other proteins like REM1_SCHPO (meiosis-specific cyclin) .